Loading clinical trials...
Loading clinical trials...
A Phase 2 Study of Nivolumab Plus Ipilimumab in Previously Treated Classical Kaposi Sarcoma (CKS)
Conditions
Interventions
Nivolumab
Ipilimumab
Locations
1
Israel
Rabin Medical Center
Petah Tikva, Israel
Start Date
April 1, 2018
Primary Completion Date
September 1, 2020
Completion Date
September 1, 2022
Last Updated
December 26, 2018
Lead Sponsor
Alona Zer
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions